All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

FormBlends Open Data

Data worth checking, quoting, and improving.

Every dataset includes definitions, primary sources, update dates, caveats, CSV and JSON downloads, and a permissive attribution license.

25 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 True Cost & Transparency Index

A versioned, source-level comparison of publicly advertised U.S. GLP-1 prices, required fees, recurring all-in cost, commitments, and offer-page transparency.

Explore and download →

5 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Provider Policy Tracker

A living matrix of publicly disclosed pricing models, medication inclusion, support, shipping, and unresolved terms.

Explore and download →

5 rows•Updated 2026-08-26•CC BY 4.0

Compounding Pharmacy Verification Registry

The authoritative public tools needed to verify pharmacy identity, licenses, federal claims, inspections, recalls, and online-pharmacy status.

Explore and download →

3 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Coverage and Prior-Authorization Evidence Tracker

A source-first tracker that separates confirmed public programs from insurer-specific claims that still need reproducible evidence.

Explore and download →

3 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Compounding and Access Regulatory Timeline

A dated ledger of material FDA and CMS actions affecting GLP-1 compounding, access, and verification.

Explore and download →

51 rows•Updated 2026-09-03•CC BY 4.0

Compounded GLP-1 Price Index

The weekly all-in cash price of compounded semaglutide and tirzepatide from U.S. telehealth providers, normalized to a 28-day supply at two reference doses, with every observation dated and sourced.

Explore and download →

201 rows•Updated 2026-09-04•CC BY 4.0

FDA Peptide and GLP-1 Enforcement Tracker

A dated timeline of FDA warning letters, compounding policy, PCAC votes, shortage decisions, court rulings and FTC actions touching peptides and GLP-1 drugs, each linked to its primary source and updated weekly.

Explore and download →

13 rows•Updated 2026-09-04•CC BY 4.0

Peptide Compounding Status Table

The current FDA compounding status of the thirteen peptides and GLP-1 drugs on the FormBlends calculator, with the FDA source and its date for each.

Explore and download →

12 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Headline-to-Recurring Price Gap

The measured difference between a public introductory price and the recurring all-in monthly amount established by the same captured offer.

Explore and download →

10 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Required-Fee Burden Index

A normalized view of required program or membership fees layered on top of a publicly advertised medication price.

Explore and download →

19 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Commitment & Prepayment Index

Offers whose advertised monthly equivalent requires or rewards quarterly billing, multi-month prepayment, or a term commitment.

Explore and download →

10 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Dose-Price Escalation Index

A public-offer comparison of dose-based price increases versus explicitly flat dose pricing.

Explore and download →

25 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Included Services Disclosure Index

Whether public offers establish shipping and laboratory treatment instead of leaving those potential costs ambiguous.

Explore and download →

13 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Public Offer Transparency Rankings

Provider-level disclosure rankings derived from the same ten-field rubric applied to every captured public offer.

Explore and download →

13 rows•Updated 2026-08-26•CC BY 4.0

GLP-1 Public Price Consistency Monitor

Provider-level detection of materially conflicting price language across owned public pages and still-indexed FormBlends content.

Explore and download →